Generic Drugs are pharmaceutical medications that contain the exact same active ingredients, dosage, safety, strength, and efficacy as their brand-name counterparts. They become available only after the original pharmaceutical company’s chemical patent expires. The Generic Drugs Market size is projected to reach USD 594.99 billion by 2031 from USD 423.55 billion in 2024. The market is expected to register a CAGR of 5.0% during 2025–2031. The rising popularity of biosimilars is likely to bring new trends in the generic drugs market in the coming years.
Download PDF Copy@ https://www.theinsightpartners.com/sample/TIPRE00003414
𝐆𝐥𝐨𝐛𝐚𝐥 𝐓𝐨𝐩 𝐋𝐞𝐚𝐝𝐞𝐫𝐬 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
- Teva Pharmaceutical Industries Ltd
- Viatris Inc
- Dr. Reddy’s Laboratories Ltd
- Novartis AG
- Sun Pharmaceutical Industries Ltd
- AbbVie Inc
- AstraZeneca Plc
- Sanofi SA
- Aurobindo Pharma Ltd
- Glenmark Pharmaceuticals Ltd.
Generic Drugs Market Segmentation:
By Molecule Type
- Antidepressants
- Antihistamines
- Analgesics
- Antibiotics
- Antivirals
- Diuretics
By Indication
- Metabolic Diseases
- Cancer
- Immunology
- Respiratory Disorder
- Cardiovascular Disorder
- Neurology Disorder
- Rare Disease
By Type
- Prescription
- OTC Drugs
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
Also Available in : Korean|German|Japanese|French|Chinese|Italian|Spanish
